Targeting Leukocyte Integrin CD11b/CD18 to Improve Transplant Outcomes: A Big Step Forward

This publication has 8 references indexed in Scilit:

• Inactivating the Innate Immune Receptor CD11b With a First-in-class Monoclonal Antibody Prolongs the Survival of Kidney Allografts in Nonhuman Primates
  Transplantation, 2025
• The Integrin Receptors: From Discovery to Structure to Medicines
  Immunological Reviews, 2024
• Lymphocytes and innate immune cells in acute kidney injury and repair
  Nature Reviews Nephrology, 2024
• Long-term Kidney Transplant Survival Across the Globe
  Transplantation, 2024
• The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and Pathophysiology
  Frontiers in Immunology, 2021
• Improving the Supply and Quality of Deceased-Donor Organs for Transplantation
  New England Journal of Medicine, 2018
• Antagonism of Integrin CD11b Affords Protection against Endotoxin Shock and Polymicrobial Sepsis via Attenuation of HMGB1 Nucleocytoplasmic Translocation and Extracellular Release
  The Journal of Immunology, 2018
• Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond
  EBioMedicine, 2018